Apremilast

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Apremilast 608141-41-9  37882  PV Completion

 

[Indication] 

1. Psoriatic Arthritis (PsA): For the treatment of adult patients with active psoriatic arthritis.

2. Plaque Psoriasis: For the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.

3. Oral Ulcers Associated with Behçet’s Disease: For the treatment of oral ulcers associated with Behçet’s disease in adults.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us